| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.00093 | 1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.00099 | 1 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.00061 | 1 |